The global contraceptive market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is fuelling the global contraceptive market growth during the forecast period includes the increasing number of unplanned pregnancies and their consequences, particularly among teenage women.
Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive pills, to reduce the number of unwanted pregnancies, which is another factor that is expected to boost the demand of the market during the forecast period. An increasing number of unwanted pregnancies, given their widespread implications, is also a major factor that is expected to boost market growth. Moreover, the governments of various countries are found doing family planning programs and contraception awareness programs to expand the knowledge about contraceptives and their advantages in preventing unwanted pregnancy is also anticipated to drive the market demand during the forecast period.
The Contraceptive Market analysis includes some of the key market players such as Bayer Healthcare, Amneal Pharmaceuticals LLC, Teva Pharmaceuticals, Abbvie Inc. (Allergan PLC), Pfizer Inc., and Johnson & Johnson, among others.
Market Coverage
Competitive Landscape: Bayer Healthcare, Amneal Pharmaceuticals LLC, Teva Pharmaceuticals, Abbvie Inc. (Allergan PLC), Pfizer Inc., and Johnson & Johnson, among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Contraceptive Market by Segment
By Product
• Oral Contraceptive Pills
• Injectable Contraceptives
• Topical Contraceptives’
By Age Group
• 15–24 Years
• 25–34 Years
• 35–44 Years
• Above 44 Years
By End-User
• Homecare
• Hospitals
• Clinics
Global Contraceptive Market by Region
North America
Europe
Asia-Pacific
Rest of the World